High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005

Briccoli, A; Rocca, Michele; Salone, Mariacristina; Guzzardella, Gaetano Antonio; Balladelli, Alba; Bacci, Gaetano

doi:10.1016/j.suronc.2009.05.002

Cited by 187 publications

(154 citation statements)

References 28 publications

Supporting

Mentioning

132

Contrasting

Unclassified

Order By: Relevance

“…21 It is known that the treatment of pulmonary relapse should be imperative when possible, since the survival of patients with resection of pulmonary metastases is very expressive, as shown by Bacci et al, 22 who evaluated 235 patients with relapse after neoadjuvant therapy; among the patients treated with surgery, a cure was achieved in 25% of the sample. Continuing with this study, Briccoli et al 23 reaffirmed the data with 323 patients with osteosarcoma, concluding that in the patients with resectable pulmonary disease Came for an earlier appointment at any time…”

Section: Discussionsupporting

confidence: 55%

Acompanhamento do paciente tratado de osteossarcoma

Martins¹

View full text Add to dashboard Cite

Objective: To evaluate the value of post-treatment follow-up in osteosarcoma patients. Methods: Data were collected through a clinical record, with socio-demographic and clinical data, and information relating to the medical appointment. Descriptive analysis of the data was carried out. The Chi-squared test was used to associate the independent variables with attendance at scheduled follow-up appointments. Results: We found a recurrence in 59.6% of cases, of which 58% were lung related; 44% presented clinical complaints and arrived on the scheduled date of the appointment. There was no statistically significant association between the demographic characteristics and early attendance of follow-up visits. 81.3% of the cases who came for the appointment earlier than originally scheduled presented complaints compared to those who did not (p=0.005). Of the cases who presented recurrence, 12.9% attended an appointment late and those who did not present recurrence, 47.6% were late for the appointment (p=0.006). Conclusion: It is seen that the patients who came for an earlier appointment presented more complaints and were associated with the positive result of the exams carried out. The patients who had recurrence and came for an earlier appointment did not present a statistically significant difference in recurrence-free survival. It was observed that distance was not a predominant factor in late attendance at appointments. Level of Evidence II, Retrospective Study.

show abstract

Section: Discussionsupporting

confidence: 55%

Acompanhamento do paciente tratado de osteossarcoma

Martins¹

View full text Add to dashboard Cite

show abstract

“…As 80% of osteosarcoma patients exhibit metastatic disease at diagnosis, the majority are treated with multi-agent chemotherapy in addition to surgical resection. As expected, patients who present with metastases have a worse prognosis and the 5-year survival rate of these patients is only 20-40% (3). The aim of the present study was to increase knowledge with regard to osteosarcoma and to discuss the clinical presentation, diagnosis, treatment and prognosis of the disease.…”

mentioning

confidence: 84%

“…had an irregular shape and measured 1.5x1x3cm 3 . The final pathological examination confirmed the diagnosis of a chondroblastic osteosarcoma without involvement of the para-tumor tissues (Fig.…”

Section: A B C Dmentioning

confidence: 99%

Chondroblastic osteosarcoma secondary to fibrosarcoma: A case report and literature review

Zheng

Yang

2015

Oncology Letters

View full text Add to dashboard Cite

Abstract. Osteosarcoma, which is most common in non-blood systemic tumors, accounts for 20% of primary bone malignancies. Primary osteosarcoma usually occurs in young individuals aged 10-20 years, while secondary osteosarcoma is more common in the elderly. It had been reported that secondary osteosarcoma may be associated with osteofibrous dysplasia, bone infarction, chondrosarcoma or osteogenesis imperfecta. However, osteosarcoma secondary to fibrosarcoma has rarely been reported. The current study presents the rare case of a female with chondroblastic osteosarcoma secondary to fibrosarcoma. The patient was relatively young and suffered from more than one type of cancer. The course of the disease lasted for >20 years. This case study provides general knowledge of osteosarcoma, and discusses its clinical presentation, diagnosis, treatment and prognosis.

show abstract

“…Metastatik olsa dahi, prensip olarak, komple tümör rezeksiyonunun yapılabilmesi çok önemlidir. [16,17] …”

Section: Metastatik Os'de Tedaviunclassified

Malign kemik tümörlerinde kemoterapi

Yalçın¹,

Beyazit²,

Onkoloji³

2014

TOTBID

View full text Add to dashboard Cite

Primary malignant bone tumours are rare neoplasms. However, osteosarcoma, chondrosarcoma and Ewing's sarcoma are also included in this group of tumours. In the last 40 years, systemic chemotherapies coupled with surgical resections have provided significant improvements in survival. Surgery alone has a limited success, particularly in the treatment of osteosarcoma and Ewing's sarcoma. Lately, the success of targeted treatment agents in the treatment of metastatic disease increases hopes.

show abstract

High grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005

Cited by 187 publications

References 28 publications

Acompanhamento do paciente tratado de osteossarcoma

Acompanhamento do paciente tratado de osteossarcoma

Chondroblastic osteosarcoma secondary to fibrosarcoma: A case report and literature review

Malign kemik tümörlerinde kemoterapi

Contact Info

Product

Resources

About